Jump to main content
Jump to site search

Issue 6, 2017

Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors

Author affiliations

Abstract

The use of imaging agents to visualize tumor cells is an advantageous technique to achieve a more efficient intraoperative diagnosis and effective debulking operations. Targeting of these agents to certain receptors that are overexpressed in cancer cells, such as the folate receptor, aids in tumor targeting. Several imaging probes have been developed using this strategy. However, these ligand-targeting cancer imaging probes are rapidly cleared during systemic delivery due to their small size, which compromises their biodistribution and circulation. Improving the detection of cancer requires higher accumulation and effective retention activities of imaging probes. Here we developed a new design for a folate-fluorophore conjugate that is modified with palmitoyl. Palmitic acid has a strong binding affinity with human serum albumin (HSA), which has the ability to form non-covalent host–guest complexes and has a blood half-life of 19 days. In this strategy, HSA is expected to serve as an endogenous nanocarrier for the designed probe in blood circulation. We hypothesized that via a reversible interaction with HSA, this simple palmitoyl modification on a folate–fluorophore conjugate can induce long blood circulation of the probe. Our folate-targeted probe could show longer blood circulation compared to the probe which lacks palmitoyl.

Graphical abstract: Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors

Supplementary files

Article information


Submitted
28 Feb 2017
Accepted
01 Apr 2017
First published
07 Apr 2017

Med. Chem. Commun., 2017,8, 1190-1195
Article type
Research Article

Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors

E. Nakhaei, C. W. Kim, D. Funamoto, H. Sato, Y. Nakamura, A. Kishimura, T. Mori and Y. Katayama, Med. Chem. Commun., 2017, 8, 1190 DOI: 10.1039/C7MD00102A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.


Search articles by author

Spotlight

Advertisements